ROBERT L. ZERBE, M.D. - Corporate Board Profile

Vericel Corp

Filing Date	Source Excerpt
2016-03-18	Robert L. Zerbe, M.D., a Director since January 2006 and Chairman of the Board of Directors since October 2012, is the Chief Executive Officer of QUATRx Pharmaceuticals Company... Mr. McLaughlin (Chair), Mr. Rubino and Dr. Zerbe were members of the Audit Committee during the fiscal year ended December 31, 2015... Ms. Hagen (Chair), Dr. Zerbe and Dr. Wotton were members of the Governance Committee during the fiscal year ended December 31, 2015... DIRECTOR COMPENSATION FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2015: Robert L. Zerbe: Total $128,330.
2017-03-20	Robert L. Zerbe, M.D., a Director since January 2006 and Chairman of the Board of Directors since October 2012...Mr. McLaughlin (Chair), Mr. Rubino and Dr. Zerbe were members of the Audit Committee during the fiscal year ended December 31, 2016...Ms. Hagen (Chair), Dr. Zerbe and Dr. Wotton were members of the Governance Committee during the fiscal year ended December 31, 2016...DIRECTOR COMPENSATION FOR THE YEAR ENDED DECEMBER 31, 2016...Robert L. Zerbe 80,000 30,228 110,228
2018-03-22	Robert L. Zerbe, M.D., a Director since January 2006 and Chairman of the Board of Directors since October 2012...Mr. McLaughlin (Chair), Mr. Rubino and Dr. Zerbe were members of the Audit Committee during the fiscal year ended December 31, 2017...Ms. Hagen (Chair), Dr. Zerbe and Dr. Wotton were members of the Governance Committee during the fiscal year ended December 31, 2017...DIRECTOR COMPENSATION FOR THE YEAR ENDED DECEMBER 31, 2017...Robert L. Zerbe 80,000 Fees Earned or Paid in Cash, 31,817 Option Awards, Total 111,817.
2019-03-20	Robert L. Zerbe, M.D., a director since January 2006 and Chairman of the Board of Directors since October 2012...Mr. McLaughlin (Chair), Mr. Rubino and Dr. Zerbe were members of the Audit Committee...Ms. Hagen (Chair), Dr. Zerbe and Dr. Wotton were members of the Governance Committee...DIRECTOR COMPENSATION FOR THE YEAR ENDED DECEMBER 31, 2018: Robert L. Zerbe: $242,644 total compensation.
2020-03-20	Robert L. Zerbe, M.D., a director since January 2006 and the Chairman of our Board of Directors since October 2012... Mr. McLaughlin (Chair), Mr. Rubino and Dr. Zerbe were members of the Audit Committee during the fiscal year ended December 31, 2019... Ms. Hagen (Chair), Dr. Zerbe and Dr. Wotton were members of the Governance Committee during the fiscal year ended December 31, 2019... DIRECTOR COMPENSATION FOR THE YEAR ENDED DECEMBER 31, 2019: Robert L. Zerbe: $253,085.
2021-03-19	Robert L. Zerbe, M.D., has served as a director of Vericel since January 2006 and as the Chairman of our Board of Directors since October 2012. ... Dr. Zerbe received his M.D. from the Indiana University School of Medicine... The Board of Directors believes Dr. Zerbe’s qualifications to serve on our Board of Directors include his senior management positions at major pharmaceutical companies and his clinical development experience. ... Vericel Board committee(s): Audit and Governance and Nominating Committees ... Director compensation table: Robert L. Zerbe Fees Earned or Paid in Cash($) 80,000, Stock Awards($) 25,480, Option Awards($) 117,439, Total($) 222,919.
2022-03-17	Robert L. Zerbe, M.D. has served as a director of Vericel since January 2006 and as the Chairman of our Board of Directors since October 2012. ... The Board of Directors believes Dr. Zerbe’s qualifications to serve on our Board include his senior management positions at major pharmaceutical companies and his clinical development experience. ... Vericel Board committee(s): Audit Committee ... Chairman of the Board ... Audit Committee Chairperson: Kevin F. McLaughlin, Members: Alan L. Rubino, Robert L. Zerbe, M.D. ... Director compensation table: Robert L. Zerbe total $510,595.
2025-03-20	Robert Zerbe, M.D., 74 Independent Chairman of the Board Retired Chief Executive Officer, QUATRx Pharmaceuticals Company Director Since: 2006 Vericel Board committee(s): Audit Committee Director compensation table: Total $469,898